Fatigue News and Research

RSS

Depression in arthritis patients

Patients with rheumatoid arthritis are twice as likely to experience depression but are unlikely to talk to a doctor about it, according to researchers at the University of North Carolina at Chapel Hill.

21 Feb 2008

FDA approves XYZAL (levocetirizine dihydrochloride) for allergies and chronic idiopathic urticaria

UCB and sanofi-aventis have announced that the U.S. Food and Drug Administration (FDA) approved a New Drug Application (NDA) for XYZAL (levocetirizine dihydrochloride) 0.5 mg/mL oral solution, a prescription antihistamine indicated for the relief of symptoms associated with indoor and outdoor allergies, as well as the treatment of chronic idiopathic urticaria.

20 Feb 2008

Depression in seniors

Depression is sometimes viewed as a normal part of aging.

13 Feb 2008

What do marathoners and heart failure patients have in common?

The new study shows that the fatigue that marathoners and other extreme athletes feel at the end of a race is caused by a tiny leak inside their muscles that probably also saps the energy from patients with heart failure.

12 Feb 2008

Potential method for repairing misspelling in DNA code that causes spinal muscular atrophy

Researchers at the University of Delaware have discovered a novel technique - that acts like a "spell-checker" for correcting a misspelling in the DNA code - to repair the defective gene that causes spinal muscular atrophy (SMA).

12 Feb 2008

Doctors uncertain about approaches to care for heart failure patients

Less than one fourth of physicians specializing in geriatrics, internal or family medicine or cardiology believe they can accurately predict the whether patients with heart failure are at risk of dying, new Saint Louis University research found.

12 Feb 2008

Nausea from chemotherapy explained

A new study from the Monell Center increases understanding of the biological mechanisms responsible for the nausea and vomiting that often afflict patients undergoing chemotherapy.

4 Feb 2008

M. D. Anderson, AstraZeneca form alliance to advance understanding of cancer-related pain

The University of Texas M. D. Anderson Cancer Center and AstraZeneca (NYSE:AZN) today announced that they will collaborate to help advance understanding of neuropathic pain caused by cancer chemotherapy, a side effect that often limits optimal therapeutic dosing in cancer treatments.

25 Jan 2008

Hawthorn extract helps the heart

Taking hawthorn extract can help control symptoms of chronic heart disease such as low abilities to work and walk, and also improve a range of heart-related measurements.

24 Jan 2008

Connection between vitamin E and subsequent decline in physical function for older adults

Low serum concentration of vitamin E, an indication of poor nutrition, is associated with physical decline for older persons, according to a study in the January 23 issue of JAMA: The Journal of the American Medical Association.

23 Jan 2008

International team pinpoints the genes for lupus

An international team of researchers has pinpointed the genes involved in the auto-immune system disease lupus.

21 Jan 2008

Untreated blood disorder leads to liver cancer and arthritis

Australian researchers have discovered that more than one quarter of men with hemochromatosis develop liver cancer, arthritis and other complications.

20 Jan 2008

Male and female doctors have divergent views on women and depression

Women and men doctors have some divergent views about women and depression, according to a recent survey conducted by the Society for Women's Health Research, a Washington, D.C., based advocacy organization.

17 Jan 2008

New patent for massage tool

When 10-year veteran massage therapist Greg Polins, of PolTech, Inc., began to experience crippling pain in his thumbs and wrists from extensive deep tissue massage, he knew he had to do something to keep his job.

17 Jan 2008

Extra-hepatic manifestation of hepatitis C virus infection

In 1994, the team of Tchernev and Petrova from Alexandrovska Hospital in Sofia examined a female patient with liver cirrhosis caused by chronic Hepatitis C virus (HCV).

17 Jan 2008

FDA approves Tysabri to treat Crohn's disease

The U.S. Food and Drug Administration has approved Tysabri (natalizumab) for the treatment of moderate-to-severe Crohn's disease in patients with evidence of inflammation who have had an inadequate response to, or are unable to tolerate, conventional Crohn's disease therapies.

14 Jan 2008